Glypican‐3: a promising biomarker for hepatocellular carcinoma diagnosis and treatment

F Zhou, W Shang, X Yu, J Tian - Medicinal research reviews, 2018 - Wiley Online Library
Liver cancer is the second leading cause of cancer‐related deaths, and hepatocellular
carcinoma (HCC) is the most common type. Therefore, molecular targets are urgently …

[HTML][HTML] Tumor microenvironment, a paradigm in hepatocellular carcinoma progression and therapy

M Tahmasebi Birgani, V Carloni - International journal of molecular …, 2017 - mdpi.com
Hepatocellular carcinoma (HCC) is among the most lethal and prevalent cancers in the
human population. Different etiological factors such as hepatitis B and C virus, alcohol and …

[HTML][HTML] Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis

X Niu, L Zhu, Y Xu, M Zhang, Y Hao, L Ma, Y Li… - BMC Public Health, 2023 - Springer
Background Alcohol related liver disease (ARLD) is one of the major chronic liver diseases
worldwide. This review aimed to describe the global prevalence, incidence, and outcomes of …

[HTML][HTML] The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability

AM Roy, R Iyer, S Chakraborty - Cell Reports Medicine, 2023 - cell.com
The tumor microenvironment (TME) is influenced by a" disorganized" extracellular matrix
(ECM) that sensitizes cancer cells toward mechanical stress, signaling, and structural …

[HTML][HTML] Endocan, sepsis, pneumonia, and acute respiratory distress syndrome

N De Freitas Caires, A Gaudet, L Portier, A Tsicopoulos… - Critical Care, 2018 - Springer
Acute respiratory distress syndrome (ARDS) and hospital-acquired pneumonia (HAP) are
major problems of public health in intensive care units (ICUs), occurring in 15% of critically ill …

Targeting syndecan-1: new opportunities in cancer therapy

Z Yang, S Chen, H Ying, W Yao - American Journal of …, 2022 - journals.physiology.org
Syndecan-1 (SDC1, CD138) is one of the heparan sulfate proteoglycans and is essential for
maintaining normal cell morphology, interacting with the extracellular and intracellular …

[HTML][HTML] Syndecan-1 (CD138), carcinomas and EMT

JR Couchman - International journal of molecular sciences, 2021 - mdpi.com
Cell surface proteoglycans are known to be important regulators of many aspects of cell
behavior. The principal family of transmembrane proteoglycans is the syndecans, of which …

[HTML][HTML] Proteoglycans in liver cancer

K Baghy, P Tátrai, E Regős… - World journal of …, 2016 - ncbi.nlm.nih.gov
Proteoglycans are a group of molecules that contain at least one glycosaminoglycan chain,
such as a heparan, dermatan, chondroitin, or keratan sulfate, covalently attached to the …

[HTML][HTML] Biomarkers in hepatocellular carcinoma: current status and future perspectives

Y Pan, H Chen, J Yu - Biomedicines, 2020 - mdpi.com
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and one of the
leading causes of cancer-related death worldwide. HCC is highly heterogeneous, both …

Endothelial glycocalyx as biomarker for cardiovascular diseases: mechanistic and clinical implications

YH Kim, P Nijst, K Kiefer, WHW Tang - Current heart failure reports, 2017 - Springer
Introduction The endothelial surface layer is covered with abundant proteoglycans, of which
syndecans and glycosaminoglycans are major constituents. Recent Findings Among the …